StonvexLoading…
StonvexCore line items from ENB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | C$29.33B | C$25.89B | C$24.10B | C$23.92B |
Operating Income | C$10.96B | C$9.65B | C$8.65B | C$5.18B |
Net Income | C$7.49B | C$5.44B | C$6.19B | C$3.00B |
EPS (Diluted) | C$3.22 | C$2.34 | C$2.84 | C$1.28 |
Total Assets | C$218.47B | C$218.97B | C$180.32B | C$179.61B |
Total Liabilities | C$152.55B | C$150.08B | C$115.83B | C$116.21B |
Cash & Equivalents | C$1.09B | C$1.80B | C$5.90B | C$861.00M |
Free Cash Flow OCF − CapEx | C$3.30B | C$5.89B | C$9.55B | C$6.58B |
Shares Outstanding | 2.18B | 2.18B | 2.13B | 2.02B |